📰 Interventional Research News
Interventional Research News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Interventional Research. Real-time updates on events, politics, business and more.
March 9, 2024
Georgia Tech-led effort to improve support device options for end-stage heart failure
May 24, 2023
George Dangas, MD, PhD, MSCAI, Professor of Medicine (Cardiology), and Surgery, at the Icahn School of Medicine at Mount Sinai will serve as SCAI President for the 2023-2024 term. He is also Director of Cardiovascular Innovation at the Zena and Michael A. Wiener Cardiovascular Institute at Icahn Mount Sinai and Chief of Cardiology at Mount Sinai Queens, and the first Mount Sinai cardiologist to hold this position.
May 23, 2023
George Dangas, MD, PhD, MSCAI, Professor of Medicine (Cardiology), and Surgery, at the Icahn School of Medicine at Mount Sinai will serve as SCAI President for the 2023-2024 term. He is also Director of Cardiovascular Innovation at the Zena and Michael A. Wiener Cardiovascular Institute at Icahn Mount Sinai and Chief of Cardiology at Mount Sinai Queens, and the first Mount Sinai cardiologist to hold this position.
January 30, 2022
The combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2 is not more effective than remdesivir alone for treat
January 30, 2022
The combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2 is not more effective than remdesivir alone for treating adults hospitalised with COVID-19, according to recent research.
January 30, 2022
The combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2 is not more effective than remdesivir alone for treat
January 28, 2022
A clinical trial has found that the combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus
January 28, 2022
This scanning electron microscope image shows SARS-CoV-2 (round gold particles) emerging from the surface of a cell cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19.NIAID
January 28, 2022
A new study has found that the combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2 is not more effective than remdesivir alone for treating adults hospitalised with COVID-19.